Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
8
×
life sciences
national blog main
national top stories
8
×
boston blog main
boston top stories
new york top stories
fda
new york blog main
san francisco top stories
san francisco blog main
san diego blog main
san diego top stories
biotech
europe top stories
national
allergan
boston
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
drugs
europe blog main
indiana blog main
indiana top stories
marc goodman
new york
raleigh-durham blog main
raleigh-durham top stories
roche
seattle blog main
seattle top stories
svb leerink
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
What
drug
8
×
medicine
8
×
fda
approved
new
cancer
oks
patients
post
specifically
weight
aces
afternoon
alkermes
alnylam
alnylam’s
announced
antipsychotic
atrophy
benefits
big
brexanolone
caveats
ceo
cholesterol
commonly
daily
data
deeper
depression
designed
devastating
disease
disorder
dna
effect
eisai
evrysdi
fast
fatty
Language
unset
Current search:
medicine
×
drug
×
" clinical trials "
×
" national top stories "
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
5 years ago
FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug